Form 4: IDEXX Laboratories Director M. Anne Szostak Reports Stock Transactions

M. Anne Szostak, a director at IDEXX Laboratories, reported gifting and selling shares of common stock, according to a recent SEC Form 4 filing.

Summary

• On September 5, 2024, M. Anne Szostak, a director of IDEXX Laboratories, gifted 500 shares of common stock to the Trust of M. Anne Szostak and 500 shares to The O'Hanian-Szostak Family Foundation.
• On September 6, 2024, she sold 500 shares of IDEXX common stock at a weighted average price of $469.3723 per share, with prices ranging from $468.98 to $469.55.
• Following these transactions, Szostak indirectly owns 6,061 shares through the Trust of M. Anne Szostak and zero shares through The O'Hanian-Szostak Family Foundation.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice and provides transparency to the market.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company director.
• The impact is likely minimal given the relatively small number of shares involved.

Key Dates